Company Overview
About Cognito Therapeutics
Cognito Therapeutics is developing a non-pharmacological treatment for Alzheimer's disease using coordinated gamma-frequency light and sound stimulation — a technology called sensory entrainment that modulates neural oscillations implicated in the disease. The company raised an oversubscribed $105 million Series C in March 2026 led by Morningside Ventures, with its pivotal HOPE clinical trial fully enrolled and topline data expected in late 2026.
Business Model & Competitive Advantage
The Spectris device delivers 40Hz light and sound stimulation through a wearable headset in daily 1-hour home sessions, targeting the gamma brainwave dysfunction that precedes and accompanies Alzheimer's. MIT-originated research demonstrated that 40Hz sensory stimulation reduced amyloid plaques and tau tangles in preclinical models — spurring a clinical development program that now includes the fully enrolled HOPE trial, which will be the definitive test of the approach in humans.
Competitive Landscape 2025–2026
If HOPE trial results are positive, Cognito would have a novel, home-use medical device with no direct pharmacological comparator in the Alzheimer's market — an enormous commercial opportunity given the disease's prevalence and the side-effect profiles of existing pharmacological options. An FDA submission pathway follows positive topline data, making late 2026 and 2027 pivotal for the company's trajectory.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Cognito Therapeutics is an emerging player bringing innovative solutions to the MedTech market.
Growth Stage
Cognito Therapeutics has achieved $105M in revenue, demonstrating strong product-market fit.
Frequently Asked Questions
Not So Random Others
a2z Radiology AI
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disea
Plenty
Plenty is a San Francisco-based indoor vertical farming company that uses AI, machine learning, and robotics to grow leafy greens and other produce in controlled indoor environments. The company has r
Oura
Oura is the maker of the Oura Ring, a premium smart ring that tracks sleep, recovery, readiness, and health metrics through continuous biometric sensing. The company raised $900 million in Series E fi
Adept AI
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and exec
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Honda
Honda Motor Co., Ltd. is a Japanese multinational mobility conglomerate founded in 1948 by Soichiro Honda and Takeo Fujisawa in Hamamatsu, Japan. Starting as a motorcycle manufacturer, Honda expanded
Compare Cognito Therapeutics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Cognito Therapeutics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Cognito Therapeutics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Cognito Therapeutics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →